The effects of D NA interacting drugs on: (1) total RNA synthesis catalyzed by E .coli and T7 RN A polymerase; (2) synthesis of the initiating dinucleotide (pppApU ) by E .coli RNA polymerase ("abortive initiation"); (3) elongation of RNA chains synthesized by T7 RNA polymerase on pT7-7 plasmid DNA bearing T7 RNA polymerase prom oter cf> 10 with human Cu/Zn superoxide dismutase coding sequence, (4) interaction of transcription factor Spl and its binding site were studied. Intercalating ligands which form quickly dissociating complexes with D N A (anthracyclines, proflavine, ethidium bromide) are compared with the slowly dis sociating drug of d(G -C ) specificity (actinomycin D), the non-intercalating, d (A -T ) specific pyrrole antibiotics (netropsin and distamycin A) and covalently binding to D N A 1-nitroacridine derivative (nitracrine). The obtained results indicate that rapidly dissociating ligands, proflavine and ethidium bromide, inhibit total RNA synthesis in vitro and the abortive initia tion to a similar extent while they do not induce discrete elongation stops of RN A polymer ase. Actinomycin D and nitracrine exhibit a high inhibitory effect on total R N A synthesis and induce stops of RN A polymerase while not affecting abortive initiation. Pyrrole antibiot ics primarily inhibit the initiation, while no elongation stops are induced. Actinomycin D inhibits complex form ation between nuclear proteins and the Spl binding site. Netropsin, ethidium bromide, proflavine and other intercalating acridines do not affect Spl binding. The results indicate that the effects primarily depend on sequence specificity and secondarily on the dissociation rate of ligands from their complexes with DNA.
In tro d u ctio n A n u m b er of com pounds affect the biological p ro p erties of nucleic acids at the m olecular level th ro u g h physicochem ical interactions o r by cova lent binding w ith D N A . N on-covalently in teract ing ligands form eith er intercalative o r non-intercalative com plexes of different equilibrium binding strength, varying in D N A sequence speci ficity and the rates of association and dissociation (K rakow and K um ar, 1980; G ale et al., 1981; A bbreviations: DOX, doxorubicin, trade name Adriamycin; DRB, daunorubicin; ACT, actinomycin D; DST, distamycin A; NT, netropsin; EB, ethidium bromide; PF, proflavin; NC, nitracrine; AAC, N-[2-dimethylamino)-ethyl]-9-aminoacridine-4-carboxamide; 2MAAC, 2-methoxy-derivative of AAC; DACA, N-[2-dimethylamino)ethyl]acridine-4-carboxamide; pT7-7 SOD, pT7-7 plasmid bearing T7 RNA polymerase prom oter cf> 10 with human Cu/Zn superoxide dismutase sequence; HU-VEC, human umbilical vein endothelial cells; IC50 and IA 50 are drug concentrations resulting in 50% decrease in RNA and pppA pU synthesis.
G niazdow ski and Tomasz, 1999). A n assay resp o n sive to all these effects is D N A -d ep en d en t R N A synthesis which can be p erform ed in cell-free sys tems. D epending on the character of interactions of drugs with D N A they m ay differently affect se quential steps of the transcription process (Sarris et al., 1977; Straney and C rothers, 1987) . The aim of these experim ents is to com pare the effects of archetypal D N A -interacting ligands on (1) total R N A synthesis catalyzed by E.coli or phage T7 R N A polym erase; (2) synthesis of the initiating di nucleotide (p p p A p U ) by E .coli R N A polym erase on early phage T7 p ro m o ter (abortive initiation) and (3) elongation of R N A chains synthesized by T7 R N A polym erase on pT7-7 plasm id D N A bearing T7 R N A polym erase p rom oter < $ > 10 with hum an C u/Z n superoxide dism utase coding se quence (pT7-7 SO D ). Ligands of low D N A se quence specificity form ing rapidly dissociating com plexes with DNA: proflavin (PF) and e th i dium brom ide (E B ) are com pared w ith slowly dis sociating drugs of high sequence specificity i.e. ac- tinomycin D (ACT), anthracycline and pyrrole antibiotics. Effects of nitracrine (NC), a l-nitro-9-acridine derivative which binds covalently to DNA upon reductive activation with dithiothreitol (Kra kow and Kumar, 1980; Gale et al., 1981; Gniazdowski and Szmigiero, 1995; Gniazdowski and Tomasz, 1999) are also assayed here. As it has been recently shown ACT in contrast to netropsin (NT), strongly inhibits binding of transcription factor Spl to its recognition site which is d(G -C ) rich (Czyz and Gniazdowski, 1998) . To evaluate the contribution of sequence specificity the effects of these drugs on protein interaction with the Spl target sequence are com pared with the effect of EB, PF and some other acridines differing in speci ficity and stability of their complexes with DNA. Farmitalia, Milan) and nitracrine (kindly provided by Professor J. Konopa, Technical University of Gdansk) were used. Phage T7 DNA, T7 DNAdependent RNA polymerase, pT7-7 SOD, an ex pression vector bearing T7 RNA polymerase pro m oter c{) 10 (kindly provided by Professor A. Ptucienniczak from the Institute of Biotechnology and Antibiotics, Warsaw) and most of other rea gents are the same as previously (Piestrzeniewicz et al., 1998a,b) . E. coli D N A -dependent RNA polymerase (Sigma-Aldrich, St. Louis) was used.
Materials and Methods

Proflavin
The inhibition of overall RNA synthesis and abortive initiation was assayed as described by Gniazdowski et al. (1988) and Piestrzeniewicz et al. (1998a) . Quantification was done by trichloro acetic acid precipitation of RNA synthesized by E. coli RNA polymerase on phage T7 DNA (over all RNA synthesis). E. coli RNA polymerase in the presence of ATP and U TP repetitively synthe sizes pppA pU on A l and A3 prom oters of phage T7 DNA (abortive initiation). The dinucleotide was separated by paper chrom atography from the substrates and quantitated. RNA or the initiating dinucleotide syntheses were assayed at 2 -3 drug concentrations and expressed as percentage of the controls containing no inhibitor. Drug concentra tions resulting in a 50% decrease in RNA synthe sis (IC50) or in pppA pU synthesis (IA 50) were ob tained from the inhibition curves. Electrophoretic analysis of the transcript synthesized on pT7-7 SOD by T7 RNA polymerase was perform ed as described by Piestrzeniewicz et al., (1998b) but RNA polymerase concentration was 200 units/ 0.1 ml if not otherwise specified. 1 unit of enzyme (MBI Fermentas, Vilnius) incorporates 1 nmol of ribonucleotide into DE-81 absorbable form in 60 min at 37 °C. Non-covalent ligand-DNA com plexes were assayed with the enzyme added to the reaction mixtures containing a ligand at appropri ate concentration. Nitracrine-DNA covalent com plexes were formed by incubation of the drug at indicated concentration with DNA (2.5 ng/0.1 ml), in the presence of dithiothreitol (5 mM) for lh (Tolwinska-Stanczyk et al., 1997) then used in the assay without purification.
Nuclear extracts isolated from human umbilical vein endothelial cells (H U V EC ) were used as a source of transcription factors. Double stranded oligonucleotide: 5'-A A TTC C CCGCCCCCGCC CCC-3' containing an Spl binding site (under lined) was from the prom oter region of the gene for the a v subunit of hum an vitronectin receptor. The 32P-labelled oligonucleotide containing Spl site incubated with nuclear extracts either in the presence or absence of drug was subjected to an electrophoretic mobility shift assay (see Czyz and Gniazdowski, 1998 for details).
Results and Discussion
The following steps of the reaction catalyzed by RNA polymerase can be distinguished: (1) bind ing; (2) initiation; (3) elongation and (4) term ina tion. Inhibition of RNA synthesis is observed upon action of several DNA-interacting drugs. Two mechanisms of the inhibition have been pos tulated: (1) The drug can prevent the enzyme from binding to the tem plate or from initiating. Once RNA polymerase is attached to DNA it displaces the ligand molecules and elongates the RNA chains. (2) The effect of the drug depends on its interference with the enzyme moving along the tem plate and eventually inducing prem ature ter mination. A t least three factors influence the ex tent of inhibition and its mechanism. In the series of related acridine derivatives a correlation was found between inhibition of RNA synthesis in vitro and both the propency to form intercalative complexes with DNA and the strength of the binding (Sarris et al, 1977; Atwell et a l, 1986; Piestrzeniewicz et al, 1990 Piestrzeniewicz et al, , 1998a . The non-covalently interacting acridines and EB form com plexes with D N A which dissociate within milli seconds (Table I) . Their primary mechanism of action on RNA synthesis is related to the interfer ence with the enzyme binding to DNA or initia tion of RNA chains with a m inor effect on elon gation (Richardson, 1973; Sarris et al, 1977; Piestrzeniewicz et al, 1998a) . This mechanism in our experiments is manifested by a similar inhibi tion of total RNA synthesis (IC50) and the synthe sis of the initiating dinucleotide, pppA pU (IA 50) by PF, EB (Table I ) and several other acridine de rivatives which form relatively slowly dissociating complexes with DNA with time constants of 0 .3 -2.2 s (Richardson, 1973; Sarris et al, 1977; Piestr zeniewicz et al, 1990 Piestr zeniewicz et al, , 1998a . Contribution of strength, stability and specificity of binding to D N A is commonly illustrated by effects of ACT which forms a long-living complex with a dissoci ation rate of 6 min (Table I) with almost strict requirem ent for d(G -C ) base pairs for binding (Gale et al, 1981) . This drug exhibits a preferential effect on elongation of RNA chains (Sarris et al, 1977) . A product synthesized by R N A polymerase in the presence of ACT shows a num ber of discrete bands corresponding to site-specifically term inated RNA chains (White and Phillips, 1989; Piestrzeniewicz et al, 1998b , see also Fig. 1 , panel A lanes 2 and 7 and panel B lane 2). Site-specific term ination of transcription is also observed with NC (Fig. 1A, lanes 4 and 5, Fig. IB lane 5) . This highly cytotoxic l-nitro-9-aminoalkylacridine de rivative, activated by sulfhydryl compounds, binds to DNA covalently with preference to purines, particularly to guanine (see review Gniazdowski and Szmigiero, 1995) . Like other covalently bind ing drugs, under these conditions NC exhibits a high effect on elongation (see review Gniazdowski and Cera, 1996) . In our experiments this effect is illustrated by the discrete bands which are formed when DNA preincubated with the drug and dithio- threitol was used as a tem plate (Fig. 1 panel A , lanes 4 and 5; panel B, lane 5). The band pattern is similar to that of ACT, a fact which is otherwise consistent with NC preference to guanine. In con trast to EB, PF, DST and NT both drugs exhibit a very low effect on abortive initiation (Table I) . Low content of guanine in the prom oter region, its absence in the tem plate segment transcribed into pppApU, and drug sequence or base specificity may explain the apparent lack of sensitivity of abortive initiation to ACT and NC (IA 50 > 15). In the latter case bulky adducts are scarcely distrib uted along the template. Hence probability for RNA polymerase to encounter the drug is higher for the elongating enzyme, i.e. when overall RNA synthesis is assayed, than for the enzyme bound to the prom oter region repetitively synthesizing the dinucleotide.
As shown by Kriebardis et al. (1987) , D RB ex hibits a considerably lower inhibitory effect on abortive initiation than on overall RNA synthesis and similar difference is found for D O X (Table I) . These effects are consistent with preference of these drugs to d (G -C ) sequences. As found by White and Phillips (1989) the dissociation rate of DOX-DNA complex (a half life of 0.8 s, and pre sumably similar for D R B ) is too high to induce specific stops of T7 RNA polymerase. Hence, in contrast to ACT and NC, in the presence of DRB or DOX no site -specific term inations of tran scription are observed ( Fig. 2A lanes 3,5 and 7 , Fig. 2B lane 2) . However, the situation differs dra matically when anthracyclines are activated with Fe(III) ions and dithiothreitol to form covalent complexes with DNA. As shown by Cullinane and Phillips (1990) an increase of inhibition and spe cific blockage sites of transcription are observed ( Fig. 2A, lanes 2,4,6) .
On the other hand pyrrole antibiotics exhibit a higher effect on the abortive initiation. IA 50 values for DST and NT are twofold and fourfold lower respectively than corresponding values of IC50 (Table I) . Both drugs, which are DNA-m inor groove binding non-intercalating ligands, are char acterized by d(A • T) specificity. Hence their rela tively higher effects on pppA pU synthesis has been expected and confirmed earlier observations on DST preferential inhibition of initiation of RNA chains by E. coli RNA polymerase (Puschendorf et al., 1974) . Surprisingly in contrast to ACT they do not induce specific stops in the tran scription of DNA by RNA polymerase (Fig. IB,  lanes 3,4) . NT and DST bind tightly to d(A -T ) clusters consisting of four and five base pairs, respectively (Bailly and Chaires, 1998) , stabilizing double helical DNA structure (Krakow and Ku mar, 1980) . There is no data available about disso ciation rates of complexes of pyrrole antibiotics with DNA but their stability is considerably higher than that of ACT. Although there are five se quences consisting of at least five consecutive d(A -T ) base pairs located downstream the pro m oter in pT7-7SOD plasmid DNA (Hallewell et al., 1985) which are potential binding sites for the pyrrole antibiotics, no corresponding stops of RNA polymerase are observed ( Fig. IB lanes 3,4) . The only explanation is that the bound drugs which interact with the m inor groove are no bar riers for the elongating enzyme which bypasses them reading the tem plate without unwinding. Several general and selective transcription factors and other regulatory proteins, in addition to RNA polymerase, are required for specific tran scription to occur. Many of them exert their func tions through specific contacts either in the pro-m oter region or distant sequences enhancing or attenuating the initiation. These contacts may be affected by anticancer drugs and related ligands, which then may lead to alteration of the transcrip tion (Hurst, 1996) . S pl, a transcription activating factor, specifically recognizes the d(G -C ) rich D NA sequences. Its binding to DNA is abolished by ACT and DOX, m ethotrexate and other drugs preferentially interacting with d(G -C ) rich se quences. On the other hand two pyrrole antibiot ics, DST and NT, which exhibit d(A -T ) specificity, do not affect the interaction of Spl with DNA (Chiang et al., 1998, Czyz and Gniazdowski, 1998, see also Gniazdowski and Czyz, 1999 , for the re view). ACT binds via intercalation to DNA prefer ably at the G pC sequence. It was suggested that the effect of ACT on Spl was due to the presence of this sequence in Spl binding site (Czyz and Gniazdowski, 1998) . ACT-and NT-DNA com plexes differ in their steric properties. To evaluate the possibility that any intercalating drug may ef fectively com pete with Spl for its binding site, EB and PF and other acridine derivatives forming intercalative complexes with DNA of different base pair preferences and different dissociation rates were assayed (Fig. 3) . N either NT, EB, PF nor car boxamide derivatives of acridines whose dissoci ation rates of their complexes with DNA varied from few milliseconds (PF, EB) to seconds (2MAAC) and preference to d(G -C ) rich se quences from negligible (PF) up to sixfold higher binding constant to poly d(G • C) over poly d (A -T ) for 2M AAC (see Piestrzeniewicz et al., 1990) significantly affect form ation of protein-oligonucleotide complex (see Fig. 3 and the legend). Up to 10-20% of inhibition is found at a drug concentration as high as 10 (im or 20 (im (not shown). 50% of inhibition of protein binding to Spl site is not reached at 50 |j,m 2M AAC or DACA (not shown). It is worth mentioning that DACA belongs to most promising anticancer drugs pres ently under clinical studies. U nder these experi mental conditions 50% inhibition of Spl binding was obtained when 1 [xm ACT was used (Czyz and Gniazdowski, 1998) . These observations support a notion that in most cases DNA specificity of a drug plays an essential role in their effect on regu lation of transcription (Gniazdowski and Czyz, 1999) .
